Brief: Galapagos Announces Nomination Of Gino Santini To Its Board Of Directors
26/03/2026 20:48
March 26 (Reuters) - Galapagos NV GLPG.AS: GALAPAGOS ANNOUNCES NOMINATION OF GINO SANTINI TO ITS BOARD OF DIRECTORS GALAPAGOS NV: PROPOSED APPOINTMENT OF GINO SANTINI AS NON-EXECUTIVE INDEPENDENT DIRECTOR, WITH INTENTION TO APPOINT HIM AS CHAIR Source text: ID:nGNX1VK6kY Further company coverage: GLPG.AS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline